Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Monitoring molecular markers associated with antimalarial drug resistance in south-east Senegal from 2021 to 2023.
J Antimicrob Chemother
January 2025
Institut Pasteur de Dakar, Immunophysiopathology and Infectious Diseases Department, G4-Malaria Experimental Genetic Approaches and Vaccines Unit, Dakar, Senegal.
Background: Since 2006, artemisinin-based combination therapies (ACTs) have been introduced in Senegal in response to chloroquine resistance (CQ-R) and have shown high efficacy against Plasmodium falciparum. However, the detection of the PfKelch13R515K mutation in Kaolack, which confers artemisinin resistance in vitro, highlights the urgency of strengthening antimalarial drug surveillance to achieve malaria elimination by 2030.
Objective: To assess the proportion of P.
SARS-CoV-2 Omicron XBB infections boost cross-variant neutralizing antibodies, potentially explaining the observed delay of the JN.1 wave in some Brazilian regions.
IJID Reg
March 2025
Laboratory of Respiratory Viruses, Exanthematous and Enteroviruses and Viral Emergencies, Oswaldo Cruz Institute, Rio de Janeiro, Brazil.
Unlabelled: The SARS-CoV-2 JN.1 lineage emerged in late 2023 and quickly replaced the XBB lineages, becoming the predominant Omicron variant worldwide in 2024. We estimate the epidemiologic impact of this SARS-CoV-2 lineage replacement in Brazil and we further assessed the cross-reactive neutralizing antibody (NAb) responses in a cohort of convalescent Brazilian patients infected during 2023.
View Article and Find Full Text PDFEvaluation of autophagic and apoptotic markers during infection with animal virus causing hemorrhagic fever in rabbits.
Front Microbiol
January 2025
Institute of Biology, University of Szczecin, Szczecin, Poland.
Introduction: /GI.1 and GI.2 cause severe Rabbit Haemorrhagic Disease, and immune processes are among the important pathomechanisms of the disease.
View Article and Find Full Text PDFGlobal prevalence and risk factors of fatigue and post-infectious fatigue among patients with dengue: a systematic review and meta-analysis.
EClinicalMedicine
February 2025
School of Nursing, College of Nursing, Taipei Medical University, Taipei, Taiwan.
Background: Fatigue during the acute phase of dengue infection can persist as post-infectious fatigue (PIF), potentially impacting quality of life. We aimed to determine the prevalence and risk factors of fatigue and PIF among dengue patients.
Methods: This systematic review and meta-analysis was registered in the PROSPERO (CRD42024543058).
Hospitalised Dengue Patients and Risk of Hypertension: A Systematic Review and Meta-Analysis.
Rev Med Virol
January 2025
Department of Respiratory Medicine, The Affiliated Hospital of Changchun University of Chinese Medicine, Changchun, China.
Identification and management of hypertension is a crucial part in hospitalised patients suffering from dengue infection (DV). Several studies with data conflicting have shown that DI may be linked to an elevated risk of hypertension in hospitalised patients. To gain a comprehensive understanding of this association, a systematic review and meta-analysis was performed.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!